患者様やご家族など一般の方向け臨床・治癒情報サイト　臨床研究情報ポータルサイト

• 進捗状況
• 試験名
• 対象疾患名
• 地域
• 登録日
•  

• Not recruiting

• Herpes Simplex Type 1 Suppression in Hepatitis C
• Chronic Hepatitis C Infection;Chronic Hepatitis C Infection;Chronic Hepatitis C Infection;Chronic Hepatitis C Infection
• United States
• 2012-04-13

• Not recruiting

• Phase 1 Study of ONT-10 in Patients With Solid Tumors
• Solid Tumors;Solid Tumors;Solid Tumors
• United States
• 2012-03-14

• Authorised

• A Phase 1/2 study to test how effective different doses of MEDI-551 is for treating subjects with Relapsing-Remitting Multiple Sclerosis
• Relapsing-Remitting Multiple Sclerosis MedDRA version: 14.1 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
• Austria, Canada, Czech Republic, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
• 2012-03-05

• Not recruiting

• Early Prevention of Preeclampsia Study
• Preeclampsia;Preeclampsia;Preeclampsia
• United States
• 2012-03-01

• Not recruiting

• Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)
• Type 1 Diabetes;Hypoglycemia
• United States
• 2012-02-29

• Not recruiting

• Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Nasopharyngeal Aspiration
• Pain
• Canada
• 2012-02-29

• Not recruiting

• Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Bladder Catheterization
• Pain
• Canada
• 2012-02-29

• Authorised

• A 1-year study to compare long-acting insulin therapies in patients with type 2 diabetes
• Type 2 Diabetes Mellitus MedDRA version: 14.1 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
• Czech Republic, Germany, Greece, Israel, Romania, Russian Federation, Spain, United States
• 2012-02-28

• Not recruiting

• A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL
• Allergic Asthma;Atopic Dermatitis;Allergic Rhinitis;Healthy Volunteers;Allergic Asthma;Atopic Dermatitis;Allergic Rhinitis;Healthy Volunteers;Allergic Asthma;Atopic Dermatitis;Allergic Rhinitis;Healthy Volunteers;Allergic Asthma;Atopic Dermatitis;Allergic Rhinitis;Healthy Volunteers
• United States
• 2012-01-31

• Not recruiting

• Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia
• Schizophrenia;Schizophrenia;Schizophrenia;Schizophrenia
• Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Luxembourg, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine, United States
• 2012-01-17

• Not recruiting

• Eating Disorders in Type 1 Diabetes: Mechanisms of Comorbidity
• Type 1 Diabetes;Eating Disorder
• United States
• 2012-01-17

• Not recruiting

• Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)
• Hepatitis C, Chronic;Hepatitis C, Chronic;Hepatitis C, Chronic;Hepatitis C, Chronic
• Germany, Poland, Russian Federation, Spain, United Kingdom, United States
• 2011-08-26

• Authorised

• The REMOVAL study: metformin in type 1 diabetes
• People with type 1 diabetes with risk factors for cardiovascular disease MedDRA version: 14.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Hormonal diseases [C19]
• Australia, Canada, Denmark, Netherlands, United Kingdom
• 2011-08-17

• Not recruiting

• Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063)
• Hepatitis C, Chronic;Hepatitis C, Chronic;Hepatitis C, Chronic;Hepatitis C, Chronic
• India, Korea, Republic of, Taiwan, United States
• 2011-07-07

• Not recruiting

• Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants
• Hepatitis C;Hepatitis C;Hepatitis C;Hepatitis C
• Argentina, Australia, Belgium, Brazil, Canada, France, Germany, Hong Kong, Hungary, Italy, Korea, Republic of, Mexico, Poland, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom, United States, Vietnam
• 2011-03-17

• Not recruiting

• A Phase 1, Dose Escalation Study of MLN7243 in Adult Patients With Advanced Solid Tumors
• Advanced Malignant Solid Tumors;Advanced Malignant Solid Tumors;Advanced Malignant Solid Tumors;Advanced Malignant Solid Tumors
• United States
• 2013-12-18

• Not recruiting

• Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
• Influenza
• United States
• 2013-12-09

• Not recruiting

• A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of Parsaclisib and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)
• B-Cell Malignancies
• United States
• 2013-12-05

• Not recruiting

• Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
• Multiple Sclerosis
• United States
• 2013-12-04

• Not recruiting

• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors
• Melanoma;Prostate Cancer;Ovarian Cancer;Renal Cell Carcinoma;Colorectal Carcinoma;Pancreatic Carcinoma;Non-small Cell Lung Carcinoma;Solid Tumors;Breast Cancer
• United States
• 2013-12-02